Register Login

RESMED INC. (RMD)

Director Farrell Michael J. 🟡 adjusted position in 5.0K shares (1 derivative) of RESMED INC (RMD) at $251.03 ($2.7M) Transaction Date: Mar 09, 2026 | Filing ID: 000016

Full text
Register to leave comments
  • News bot March 11, 2026, 12:30 p.m.

    🔍 Farrell Michael J. (Director)

    Company: RESMED INC (RMD)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 4,991
    • Total shares sold: 9,982
    • Total shares held: 2,090

    Detailed Transactions and Holdings:

    • Acquired 4,991 shares of ResMed Common Stock at $146.34 per share (Direct)
      Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 471,214.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 4,991 shares of ResMed Common Stock at $251.0322 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 466,223.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of ResMed Common Stock (Direct)
      Date: 2026-03-09 | Code: H | nature_of_ownership: Lisette and Michael Farrell Family Trust | shares_owned_after: 2,090.00
    • Sold 4,991 shares of ResMed Common Stock Options at $146.34 per share (Derivative)
      Date: 2026-03-09 | Code: M | Expires: 2026-11-21 | Exercise: 2020-11-11 | equity_swap_involved: 0 | shares_owned_after: 39,930.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
    • F2: This transaction was executed in multiple trades at prices ranging from $246.83 - $253.09. The price reported above reflects the weighted average sale price.
    • F3: Represents date options first become exercisable. Options vest 1/3 per year.

Search

News categories